UnitedHealth extended its 15-year earnings beat streak in 2024 with $3.3 billion in asset sales, raising questions about ...

It is hard to get excited after looking at UnitedHealth Group's (NYSE:UNH) recent performance, when its stock has declined 50 ...

Shares have cratered since April, when the company slashed its financial guidance and posted earnings that missed ...

Johnson & Johnson boosted its full-year outlook as it posted better-than-expected profit and sales in the second quarter. The chip-making equipment supplier, whose clients include Intel, issued a ...

Wolfe Research reaffirmed its ‘Outperform’ rating on UnitedHealth Group but cut its price target to $330 from $363, citing ongoing medical billing pressures. The firm highlighted that UnitedHealth’s ...

UnitedHealth continues to face headwinds due to regulatory scrutiny, Medicare costs, and management changes. Read more on ...

Analysts generally have a positive outlook for Elevance Health, with an ‘Outperform’ consensus rating and a decent potential ...

UnitedHealth's management has already signaled an improving outlook for the second half of 2025. Click here to read an ...

The offering, the first IPO this year, attracted more than 32 billion dirhams ($3.5 bln) in demand for 500 million dirhams in shares. GSK seeks FDA nod for expanded use of RSV vaccine in adults ...

UnitedHealth Group Inc. UNH is currently navigating a challenging healthcare landscape, with its Medicare Advantage business ...

According to a SEC filing dated July 10, Ferguson Wellman Capital Management sold 155,436 shares of UnitedHealth Group( UNH ...

A significant trading signal occurred for UnitedHealth stock, as it demonstrated a power inflow at $299.78, after which UNH ...